Statement Regarding Share Price Movement

VERONA PHARMA PLC - Statement Regarding Share Price Movement

PR Newswire

London, January 4

Statement regarding share price movement

The Company notes the recent share price movement. The Board of Verona is notaware of any reason that would lead to such a movement in the Company's shareprice. In addition, it now currently anticipates that the result of the RPL554anti inflammatory trial, previously expected around year end, will not beavailable until March 2013.

For further information please contact:

Jan-Anders Karlsson, Verona Pharma plc Tel: 020 7863 3300

Chris Fielding, WH Ireland Limited Tel: 020 7220 1650